The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
about
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumCombination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.Systemic therapy for bladder cancer - a medical oncologist's perspective.Upper tract urothelial carcinoma: impact of time to surgery.Conditional Survival in de novo Metastatic Urothelial CarcinomaVinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)Chemotherapy practices and perspectives in invasive bladder cancer.Systemic therapy for metastatic urothelial carcinoma.Current optimal chemotherapy for advanced urothelial cancer.Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysisId Proteins Contribute to Tumor Development and Metastatic Colonization in a Model of Bladder Carcinogenesis.Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis.Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.The safety and efficacy of gemcitabine for the treatment of bladder cancer.Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profilingEfficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.Recent advances in medical therapy for metastatic urothelial cancer.Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.
P2860
Q33287243-35041EED-A46B-4447-9CF7-B8D0CFF8615AQ33405638-12704E2D-380C-4F08-8074-6F367BE6C159Q34516731-EC92BD1A-722F-4D72-A0E8-018DA669371EQ34553950-5A444952-D9C5-42F4-95F9-9B47217D58E7Q35756105-92DCD68D-26B9-4930-BF09-39B0126B2FD3Q36627206-EECBBE45-8089-4677-B043-D33AA4031BD6Q36636656-419C7569-7CF0-4EAF-A0FF-CA2C4A459418Q37028356-AFD2BAF7-E526-4D0A-9D35-F5FFDBAA8D0DQ37038897-DF46D884-0954-44F4-9AD1-6B4429AAF72AQ37045540-0FD58B52-3AF0-488C-8EC9-0139F6116857Q37053962-EC958D8D-D229-4768-8C06-537150782740Q37283592-F2070043-EC9B-4FF3-BE48-4190E2A67775Q37896172-CCBF80DE-2BA1-4FF8-A1CA-220F3B6AD90FQ38701535-FF59588F-787D-4722-A619-D9163CFC4C06Q42715876-EE4C257B-AB2D-4866-AD7A-A3574C52B735Q46857042-11F9349E-D737-404E-B4E5-F8D2F5A52C77Q52382371-3E6B1B22-F132-4FBC-9893-7783D3EB322EQ52647343-40638D96-53D7-4E27-9723-D656A1CED9DBQ53250202-FF6D4A1E-CC87-453D-AA76-0DAD78B21BC8Q54770311-E8B250F1-7E27-46E4-B9FD-B09A8DB43360
P2860
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@ast
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@en
type
label
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@ast
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@en
prefLabel
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@ast
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@en
P2093
P50
P356
P1433
P1476
The combination of gemcitabine ...... ic Cooperative Oncology Group.
@en
P2093
Aggelos Koutras
Aristotle Bamias
Dimitris Pectasides
Dimitros Gika
Gerassimos Aravantinos
Haralambos P Kalofonos
Helena Linardou
Lia A Moulopoulos
P304
P356
10.1002/CNCR.21604
P407
P577
2006-01-01T00:00:00Z